1 – 50 of 168
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
(
- Contribution to journal › Article
-
Mark
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
(
- Contribution to journal › Article
-
Mark
The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
(
- Contribution to journal › Scientific review
-
Mark
The Proteome of Primary Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
The Potential of MicroRNAs as Prostate Cancer Biomarkers.
(
- Contribution to journal › Scientific review
-
Mark
Re : Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re : The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Heterogeneous Challenges for Urologic Cancers.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
(
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy.
(
- Contribution to journal › Article
-
Mark
Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting the Mechanisms of Progression in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reply from Authors re: Bas W.G. van Rhijn, Mark A. Behrendt, Kees Hendricksen, Theo H. van der Kwast. Toward Optimal Prediction of Prognosis in T1 Urothelial Carcinoma of the Bladder. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.03.030.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Prior to Radical Cystectomy: Induction Versus Neoadjuvant Chemotherapy.
(
- Contribution to journal › Letter
-
Mark
Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Genomic Predictors of Outcome in Prostate Cancer.
(
- Contribution to journal › Scientific review
-
Mark
Clinical Management of Prostate Cancer in Men with BRCA Mutations.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
(
- Contribution to journal › Article
-
Mark
Re: David J. McConkey, Woonyoung Choi, Colin P.N. Dinney. New Insights into Subtypes of Invasive Bladder Cancer: Considerations of the Clinician. Eur Urol 2014;66:609-10.
(
- Contribution to journal › Letter
-
Mark
On Molecular Classification of Bladder Cancer: Out of One, Many.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Does Incision Length Matter? Robotic Assisted Extracorporeal Urinary Diversion via Mini-laparotomy Using the Alexis O-ring Retractor.
(
- Contribution to journal › Letter
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
-
Mark
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
(
- Contribution to journal › Article
-
Mark
Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery.
(
- Contribution to journal › Article
-
Mark
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review.
2015) In European Urology(
- Contribution to journal › Scientific review
-
Mark
A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.
2015) In European Urology(
- Contribution to journal › Article
-
Mark
Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus.
2015) In European Urology(
- Contribution to journal › Scientific review
-
Mark
EAU Guidelines on Renal Cell Carcinoma: 2014 Update.
(
- Contribution to journal › Article
-
Mark
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
-
Mark
Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial.
(
- Contribution to journal › Article
- 2014
-
Mark
The Clinical Impact of Genetic Susceptibility to Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.
(
- Contribution to journal › Article
-
Mark
EAU Policy on Live Surgery Events.
(
- Contribution to journal › Scientific review
-
Mark
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
2014) In European Urology(
- Contribution to journal › Article
- 2013
-
Mark
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
(
- Contribution to journal › Scientific review
-
Mark
Infective Complications After Prostate Biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, A Prospective Multinational Multicentre Prostate Biopsy Study
(
- Contribution to journal › Article
-
Mark
The Mutational Landscape of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Antibiotic Stewardship: A Call for Action by the Urologic Community
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
(
- Contribution to journal › Scientific review
-
Mark
Intermittent Androgen-deprivation Therapy in Prostate Cancer: A Critical Review Focused on Phase 3 Trials
(
- Contribution to journal › Article
-
Mark
Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam
(
- Contribution to journal › Article